The LUTZ | ABEL team was led by Philipp Hoene (lead partner, Munich) and included Constanze Hachmann (Hamburg), Lars Dieball and Roman Krug (both Munich, all M&A), Ute Schenn and Simon Kopp (both Stuttgart, Commercial), Cornelius Renner and Jonas Kleinebrahm (both Stuttgart, IP/IT) and Claudia Knuth and Jasper Barkowski (Berlin, Employment Law). The firm advised on all aspects of the transaction, including structuring, negotiations and execution.
Founded in 2016, Tierliebhaber has established itself as a leading German brand for pet supplements and functional snacks. The company focuses on natural, high-quality products for preventive pet health and distributes its products via digital channels and B2B partnerships. The existing shareholders sold their shares as part of the transaction, while the management team will remain in place to drive future growth.
For AlphaPet, the acquisition represents an important strategic step to further expand its brand portfolio into the health and wellness segment. Tierliebhaber complements the existing offering and strengthens AlphaPet’s position in functional pet health products.
The transaction was financed through a combination of equity and debt. Patria Investments acted as lead investor, supported by Venture Stars and existing AlphaPet shareholders. Debt financing was provided by CVC.
AlphaPet was further advised by A&O Shearman (debt financing legal) as well as Deloitte and SONNTAG (tax). The sellers were advised by GÖRG, led by Dr. Philipp Grzimek.
With this acquisition, AlphaPet continues its expansion strategy and further strengthens its leading position in the European premium pet food and pet health market.